- Home
- MD vs ELVN Comparison
MD vs ELVN Comparison
Compare MD & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MD
- ELVN
- Stock Information
- Founded
- MD 1979
- ELVN 2016
- Country
- MD United States
- ELVN United States
- Employees
- MD N/A
- ELVN N/A
- Industry
- MD Hospital/Nursing Management
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- MD Health Care
- ELVN Health Care
- Exchange
- MD Nasdaq
- ELVN Nasdaq
- Market Cap
- MD 1.2B
- ELVN 1.2B
- IPO Year
- MD 1995
- ELVN 2020
- Fundamental
- Price
- MD $13.17
- ELVN $22.63
- Analyst Decision
- MD Buy
- ELVN Strong Buy
- Analyst Count
- MD 6
- ELVN 5
- Target Price
- MD $16.67
- ELVN $41.20
- AVG Volume (30 Days)
- MD 637.2K
- ELVN 721.5K
- Earning Date
- MD 08-05-2025
- ELVN 08-12-2025
- Dividend Yield
- MD N/A
- ELVN N/A
- EPS Growth
- MD N/A
- ELVN N/A
- EPS
- MD N/A
- ELVN N/A
- Revenue
- MD $1,976,177,000.00
- ELVN N/A
- Revenue This Year
- MD N/A
- ELVN N/A
- Revenue Next Year
- MD $3.26
- ELVN N/A
- P/E Ratio
- MD N/A
- ELVN N/A
- Revenue Growth
- MD N/A
- ELVN N/A
- 52 Week Low
- MD $6.69
- ELVN $13.30
- 52 Week High
- MD $17.67
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- MD 39.72
- ELVN 60.45
- Support Level
- MD $13.34
- ELVN $19.38
- Resistance Level
- MD $13.68
- ELVN $21.34
- Average True Range (ATR)
- MD 0.41
- ELVN 1.27
- MACD
- MD -0.05
- ELVN 0.11
- Stochastic Oscillator
- MD 14.37
- ELVN 88.47
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.